The intermediate filaments and prognostically oriented morphological classification in ductal breast carcinoma

Neoplasma

Volumn 44, Issue 6, 1997, Pages 370-373

  Rejthar, A ^a   Nenutil, R ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Breast cancer; Classification; Cytokeratin; Histopathology; Intermediate filaments; Prognosis; Vimentin

Indexed keywords

CYTOKERATIN; VIMENTIN;

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INTERMEDIATE FILAMENT; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0031422143     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BARTEK, J., DURBAN, E.M., HALLOWES, R.C., TAYLOR-PAPADIMITRIOU, J.: A subclass of luminal epithelia cells in the mammary gland, defined by antibodies to cytokeratins. J. Cell Sci., 75, 1985, 17-33.
2. BARTEK, J., VOJTESEK, B., STASKOVA, Z., BARTKOVA, J., KEREKES, Z., REJTHAR, A., KOVARIK, J.: A series of 14 new monoclonal antibodies to keratins: Characterization and value in diagnostic histopathology. J. Pathol., 164, 1991, 215-224.
3. BELL, C.D., TISCHLER, E.M., LAROYE, G.J.: The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer. Breast Cancer Res. Treat., 33, 1995, 147-162.
4. BOCKER, W., BIER, B., FREYTAG, G., BROMMELKAMP, B., JARASCH, E.D., EDEL, G., DOCKHORN-DWORNICZAK, B., SCHMID, K.W.: An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II. Epitheliosis and ductal carcinoma in situ. Virchows Arch. A Pathol. Anat. Histopathol., 421, 1992, 323-330.
5. DOMAGALA, W., STRIKER, G., SZADOWSKA, A., DUKOWICZ, A., HAREZGA, B., OSBORN, M.: p53 protein and vimentin in invasive ductal NOS breast carcinoma - relationship with survival and sites of metastases. Eur. J. Cancer, 30A, 1994, 1527-1534.
6. DOMAGALA, W., WOZNIAK, L., LASOTA, J., WEBER, K., OSBORN, M.: Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am. J. Pathol., 137, 1990, 1059-1064.
7. FRIEDRICH, K., STURM, U., DIMMER, U., FLOSSEL, C.: Demonstration and possible prognostic value of the nucleolar organizer region (NOR), the microtubule-associated proteins 1A/ 1B (MAP) and the intermediate filaments vimentin and cytokeratin 19 in invasive ductal breast carcinoma. Zentralbl. Pathol., 140, 1994, 61-71.
8. GOULD, V.E., KOUKOULIS, G.K., JANSSON, D.S., NAGLE, R.B., FRANKE, W.W., MOLL, R.: Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Am. J. Pathol., 137, 1990, 1143-1155.
9. HEATLEY, M., MAXWELL, P., WHITESIDE, C., TONER, P.: Cytokeratin intermediate filament expression in benign and malignant breast disease. J. Clin. Pathol., 48, 1995, 26-32.
10. HEATLEY, M., WHITESIDE, C., MAXWELL, P., TONER, P.: Vimentin expression in benign and malignant breast epithelium. J. Clin. Pathol., 46, 1993, 441-445.
11. HOLCK, S., PEDERSEN, L., SCHIODT, T., ZEDELER, K., MOURIDSEN, H.: Vimentin expression in 98 breast cancers with medullary features and its prognostic significance. Virchows Arch. A Pathol. Anat. Histopathol., 422, 1993, 475-479.
12. KOUTSELINI, H., MARKOPOULOS, C., LAMBROPOULOU, S., GOGAS, H., KANDARAKI, C., GOGAS, J.: Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients. Cytopathology, 6, 1995, 14-21.
13. LARSIMONT, D., LESPAGNARD, L., DEGEYTER, M., HEIMANN, R.: Medullary carcinoma of the breast: A tumor lacking keratin 19. Histopathology, 24, 1994, 549-552.
14. LAUEROVA, L., KOVARIK, J., BARTEK, J., REJTHAR, A., VOJTESEK, B.: Novel monoclonal antibodies defining epitop of human cytokeratin 18 molecule. Hybridoma, 7, 1988, 495-504.
15. LEIGH, I.M., LANE, E.B., PURKISS, P.E.: Monoclonal antibodies to keratin 14 as a marker of keratinocyte lineage. J. Invest. Dermatol., 91, 1988, 415-422.
16. MILLIS, R.R., GIRLING, A.C.: The Breast. In: Diagnostic Surgical Pathology. Ed.: Sternberg, S.S. New York, Raven Press 1989, 217-313.
17. PERCY, C., VAN HOLTEN, V., MUIR, C.: International Classification of Diseases for Oncology. 2nd ed. Geneva, World Health Organization 1990.
18. TAKEI, H., IINO, Y., HORIGUCHI, J., KANOH, T., TAKAO, Y., OYAMA, T., MORISHITA, Y.: Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma. Anticancer Res., 15, 1995, 1101-1105.
19. THOMPSON, E.W., TORRI, J., SABOL, M., SOMMERS, C.L., BYERS, S., VALVERIUS, E.M., MARTIN, G.R., LIPPMAN, M.E., STAMPFER, M.R., DICKSON, R.B.: Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis, 12, 1994, 181-194.
20. TOMASINO, R.M., RUSSO, A., BAZAN, V., MORELLO, V., TRALONGO, V, NAGAR, C., SALVATO, M., TAORMINA, P., MARRAZZO, A., NUARA, R.: Evaluation of integrated morpho-biological indicators in breast cancer. In-Vivo, 7, 1993, 601-605.
21. VOJTĚŠEK, B., KOVAŘIK, J., NENUTIL, R., SVITÁKOVA, M., ZALOUDIK, J., DOLEŽLOVA, H., REJTHAR, A., LAUEROVA, L.: p53 protein overexpression associates with growth patterns rather than with metastazing in operable breast cancer. Neoplasma, 42, 1995, 331-336.